Newsroom

Extra! Extra!
Read all about it

Welcome to our Newsroom, your go-to source for the latest updates on Galapagos. Explore press releases, insightful blogs, and access our resource hub, complete with company materials, designed to provide media and journalists with comprehensive information about our company’s innovations and milestones

The latest

Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update

Galapagos reported its financial results for the full year 2024 and provided an update on the fourth quarter 2024 and its year-to-date performance.

The latest

NecstGen Announces a Strategic Collaboration with Galapagos to Advance Decentralized CAR-T Cell Manufacturing in Europe

NecstGen, a leading Contract Development and Manufacturing Organization (CDMO) dedicated to Cell and Gene Therapies, is proud to announce a strategic collaboration with Galapagos to support decentralized manufacturing of Galapagos’ candidate cell therapy products in Europe.

The latest

Catalent Announces Collaboration with Galapagos to Further Expand Galapagos’ Decentralized CAR-T Manufacturing Network in the U.S.

Catalent announced a strategic collaboration with Galapagos to support decentralized manufacturing for clinical studies of GLPG5101, Galapagos’ investigational CAR-T therapy for relapsed/refractory non-Hodgkin lymphoma (NHL) indications. Catalent will support manufacturing for Galapagos’ upcoming trials in New Jersey, New York, and surrounding areas.

STORIES

Press releases

Follow our journey

Subscribe to receive our press releases

Do you want to stay up to date on our journey, as we are pioneering for patients?